Levetiracetam for treatment-refractory posttraumatic stress disorder

Journal of Clinical Psychiatry

Volumn 67, Issue 2, 2006, Pages 211-214

  Kinrys, Gustavo ^a   Wygant, Lisa E ^b   Pardo, Tamara B ^b   Melo, Maria ^b  

^a CAMBRIDGE HEALTH ALLIANCE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANXIOLYTIC AGENT; CITALOPRAM; CLONAZEPAM; CLONIDINE; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; PAROXETINE; QUETIAPINE; SERTRALINE; TIAGABINE; TOPIRAMATE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; FEMALE; HAMILTON SCALE; HOSPITALIZATION; HUMAN; MALE; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REMISSION; SEDATION; TREATMENT RESPONSE; XEROSTOMIA;

EID: 33644822479     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0206     Document Type: Article

References (27)

1. Kessler RC, Sonnega A, Bromel E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52: 1048-1060
2. Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 2000;61(suppl 5):4-12
3. Vermetten E, Bremner JD. Circuits and systems in stress, 2: applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 2002;16:14-38
4. McFarlane AC, Yehuda R, Clark CR. Biologic models of traumatic memories and post-traumatic stress disorder: the role of neural networks. Psychiatr Clin North Am 2002;25:253-270
5. Friedman MJ. What might the psychobiology of posttraumatic stress disorder teach us about future approaches to pharmacotherapy? J Clin Psychiatry 2000;61(suppl 7):44-51
6. Post RM. Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms? Epilepsy Res 2002;50:203-219
7. Clark RD, Canive JM, Calais LA, et al. Divalproex in posttraumatic stress disorder: an open-label clinical trial. J Trauma Stress 1999;12:395-401
8. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999;19:341-348
9. Kinrys G, Pollack MH, Simon NM, et al. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol 2003;18:169-172
10. Taylor FB. Tiagabine for posttraumatic stress disorder: a case series of 7 women. J Clin Psychiatry 2003;64:1421-1425
11. Berlant J, Van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 2002;63:15-20
12. Hamner MB, Brodrick PS, Labbate LA. Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry 2001; 13:141-146
13. Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999;45:1226-1229
14. Noyer M, Gillard M, Montagne A, et al. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol 1995;286:137-146
15. Niespodziany I, Klitgaard H, Margineanu DG, et al. Levetiracetam: modulation of high voltage-activated calcium current in CA1 pyramidal neurons of rat hippocampal slices [abstract]. Epilepsia 2000;41 (suppl 7):37
16. Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-9866
17. LaRoche SM, Helmers SL. The new antiepileptic drugs: clinical applications. JAMA 2004;291:615-620
18. Leppik IE. Three new drugs for epilepsy: levetiracetam, oxcarbezapine, and zonisamide. J Child Neurol 2002;17(suppl 1):S53-S57
19. Lamberty Y, Gower AJ, Klitgaard H. The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice. Eur J Pharmacol 2002;439:101-106
20. Gower AJ, Falter U, Lamberty Y. Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat. Eur J Pharmacol 2003 Nov 14;481(1):67-74
21. Lamberty Y, Falter U, Gower AJ, et al. The novel drug levetiracetam (Keppra) reveals an anxiolytic profile in the punished drinking test which differs from chlordiazepoxide [poster]. Presented at UCB Pharma, Preclinical CNS Research, B-1420; 2001; Braine l'Alleud, Belgium
22. Jain KK. An assessment of levetiracetam as an anti-epileptic drug. Expert Opin Investig Drugs 2000;9:1611-1624
23. Simon NM, Worthington JJ, Doyle AC, et al. An open-label study of levetiracetam for the treatment of social anxiety disorder. J Clin Psychiatry 2004;65:1219-1222
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
25. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976
26. Blanchard EB, Jones-Alexander J, Buckley TC, et al. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther 1996;34: 669-673
27. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55